Brazil Clinical Nutrition for Diabetes Care Market Report 2023 to 2030

Brazil Clinical Nutrition for Diabetes Care Market Analysis

$ 3999

The Brazil Clinical Nutrition for Diabetes Care Market was valued at $53.75 Mn in 2023 and is predicted to grow at a CAGR of 5.78% from 2023 to 2030, to $79.65 Mn by 2030. The key drivers of this industry include increasing the prevalence of diabetes, advancements in nutritional science, and initiatives for diabetes management. The key players in the industry are Nestle Health Science, Nutribio, Pfizer Inc., and Novo Nordisk among others.

ID: IN10BRPH566 CATEGORY: Pharmaceuticals GEOGRAPHY: Brazil AUTHOR: Avantika Gupta

Buy Now

Brazil Clinical Nutrition for Diabetes Care Market Executive Summary

The Brazil Clinical Nutrition for Diabetes Care Market is at around $53.75 Mn in 2023 and is projected to reach $79.65 Mn in 2030, exhibiting a CAGR of 5.78% during the forecast period.

Clinical nutrition for diabetes care refers to specialized dietary interventions and nutritional strategies designed to manage and improve the health outcomes of people with diabetes mellitus. It involves using evidence-based nutrition treatment to help diabetic patients maintain blood sugar control, avoid complications, and enhance their overall metabolic health. The primary aim is to optimize nutrition, regulate blood sugar levels, prevent complications, and enhance overall health outcomes for those with diabetes.

The increase in the prevalence of diabetes due to aging, obesity, and unhealthy lifestyles is one of the factors contributing to the growth of the global clinical nutrition market. Obesity is a major factor leading to diabetes. Clinical nutrition including medical foods and parenteral nutrition can help relieve symptoms or slow down the progression of a chronic condition. As the number of people with diabetes continues to grow, so does the demand for these specialized food products. Patients afflicted with diabetes are at higher risk of comorbidities, as diabetes is a major cause of blindness, kidney failure, heart attacks, stroke, and lower limb amputation, as reported by the WHO.

The leading pharmaceutical companies include Abbott Nutrition, Sanofi is known for its extensive portfolio of medications, including those essential for diabetes care. Nestlé Health Science, Pfizer Inc., and Nutribio are also significant contributors to the Clinical Nutrition for Diabetes Care landscape, with continuous research and development activities.

Brazil Clinical Nutrition for Diabetes Care Market Report 2023 to 2030

Market Dynamics

Market Growth Drivers

Increasing Prevalence of Diabetes: Increasing prevalence of diabetes: According to the International Diabetes Federation, Brazil has 15.7 Mn adults (10.5% of the population) currently living with diabetes. Additionally, 18 Mn adults (11.9%) have impaired glucose tolerance, putting them at high risk of developing type 2 diabetes. This rising prevalence of diabetes is a major driver for the clinical nutrition market.

Personalized Nutrition Solutions: The clinical nutrition market in Brazil is moving towards more personalized and tailored approaches, leveraging advancements in nutrigenomics and data analytics. These solutions aim to develop customized nutritional interventions based on an individual's genetic profile, disease state, and lifestyle factors, enabling more effective management of diabetes.

Innovative Product Formulations: Advancements in nutritional science have led to the development of more effective and palatable clinical nutrition products for diabetes care. This includes the formulation of specialized products like high-protein, low-carbohydrate, and fiber-enriched options that can better meet the unique metabolic needs of diabetic patients and enhance diabetes management. mHealth apps can provide patients with educational resources, dietary tracking tools, and support for managing their diabetes through nutrition.

Market Restraints

Lack of Awareness: Improving awareness and education about the role of clinical nutrition in diabetes management is crucial for driving adoption in Brazil. Healthcare providers need training on the latest evidence-based guidelines and best practices, while patients require accessible information on how specialized nutrition can optimize diabetes control and overall health. Targeted campaigns and educational initiatives are needed to address this key barrier.

Regulatory Landscape: The regulatory approval process for new clinical nutrition products in Brazil, overseen by ANVISA, involves a comprehensive review to ensure safety, efficacy, and quality standards are met. However, this rigorous process can take significant time, with deadlines of up to 1 year for ordinary marketing authorization reviews. The complexity and length of the approval process can delay the introduction of innovative clinical nutrition products to the Brazilian market.

Competing treatment priorities: In the Brazilian healthcare system, there may be a greater focus and allocation of resources towards other aspects of diabetes care, like medications and devices, compared to clinical nutrition. This can limit investment and attention in this area.

Regulatory Landscape and Reimbursement Scenario

The regulatory landscape for clinical nutrition for diabetes care in Brazil is overseen by the National Health Surveillance Agency (ANVISA). Most specialized diabetic food items and enteral feeding formulas require registration with ANVISA before being marketed or sold in Brazil. This process involves submitting detailed information about the product's ingredients, nutritional content, intended use, and safety data. Certain types of diabetic food products, like those intended for specific medical conditions, might have additional regulations regarding nutrient composition or claims.

Public Health System (SUS) covers essential medications for diabetes and some diagnostic tests. Coverage for consultations with clinical nutritionists is generally limited. Private Insurance Plans offer more varied coverage depending on the plan and company. They offer a wider range of medications for diabetes management beyond the SUS formulary which includes consultations with a broader range of specialists, potentially including dietitians.

Competitive Landscape

Key Players

Here are some of the major key players in the Brazil Clinical Nutrition for Diabetes Care Market:

Abbott Nutrition
Novo Nordisk
Eli Lilly
Eurofarma
Nestlé Health Science
Roche Diabetes Care
Prodiet Medical Nutrition
Sanofi
Nutrimed
Danone Nutricia
Fresenius Kabi Brasil

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Brazil Clinical Nutrition for Diabetes Care Market Segmentation

By Product

Oral Nutrition
Parenteral Nutrition
Enteral Feedback Formulas

By Stage

Adult
Paediatric

By Distribution Channel

Online
Retail
Institutional Sales

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.